INDOLINE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
申请人:[en]MINDSET PHARMA INC.
公开号:WO2024044847A1
公开(公告)日:2024-03-07
The present application relates to methods of activating serotonin receptors in a cell using indoline derivatives of general Formula (I) or a pharmaceutically acceptable salt, solvate and/or prodrug thereof, as well as to treating diseases, disorders or conditions by activation of a serotonin receptors in a cell. The diseases, disorders or conditions include, for example, psychosis, mental illnesses and CNS disorders. The present application also relates to novel indoline derivatives and to compositions and uses thereof. Wherein Q is selected from (Q1), (Q2), (Q3), (Q4) (Q5) and (Q6).